Brief introduction: Guangdong Kanglian Pharmaceutical Co., Ltd. was formerly a state-owned enterprise, xingning city Pharmaceutical Factory. It was jointly funded by the listed company Guangdong Mingzhu Group Co., Ltd. and xingning city Finance Bureau and transformed into a limited liability company Guangdong Mingzhu Pharmaceutical Co., Ltd. In June 2009, xingning city Zhonglianjia Investment Co., Ltd. purchased all the shares held by Guangdong Mingzhu Group Co., Ltd. and became the controlling shareholder. The company was renamed as Guangdong Kanglian Pharmaceutical Co., Ltd., which currently covers an area of 90,000 square meters with a construction area of 25,600 square meters. Located on the banks of Ningjiang River in xingning city with beautiful environment. The main products are 72 varieties of Chinese and western medicines, including Babao Jingfeng Powder, Ginseng Health Care Pill, Fitness Antai Pill, Damp-heat Tablet, Baji Bushen Pill, Jiebiao Zhuifeng Pill and so on. The enterprise is committed to the development of Chinese patent medicine and the industrialization and modernization of Chinese medicine. In recent years, the research and promotion focusing on improving the quality and efficacy of Chinese patent medicines have achieved fruitful results. Babao jingfeng powder for children is listed as a national protected variety of traditional Chinese medicine and a well-known brand at home and abroad. Ginseng Health Pill, a patented product, is the first choice for the treatment of enuresis due to deficiency of kidney-qi and unstable nocturnal emission due to deficiency of kidney-energy. Damp-heat tablet, a patented product, is an exclusive variety of Baji Bushen Pill approved by the Ministry of Health. Enterprises pay attention to quality and strive for perfection. The introduction of high standards of main production equipment, the transformation of production workshops and corresponding supporting facilities are strictly in accordance with GMP standards, and both software (components) and hardware (components) are adhered to. The quality of products has been recognized by users and the market has been expanding. Products sell well all over the country, Hong Kong, Macao and Taiwan, Southeast Asia and the Russian border. The company adheres to the scientific research development strategy of innovation and development, and develops new products, new dosage forms and new technologies in the mode of independent development and cooperative research and development to meet the market demand. In 2006, it was recognized as a high-tech enterprise in Guangdong Province; In 2005 and 2006, it was rated as an advanced private enterprise in Meizhou for two consecutive years; It was listed as one of the 100 demonstration enterprises in Guangdong Province by Guangdong Economic and Trade Commission. Over the years, it has been recognized by Guangdong Administration for Industry and Commerce as an AAA credit enterprise of China Industrial and Commercial Bank, a super credit enterprise, a model taxpayer of Guangdong Province, an enterprise that values contracts and keeps promises, and a trustworthy enterprise of product quality by Meizhou Bureau of Quality and Technical Supervision for ten consecutive years. In order to speed up the development, according to GMP requirements, the company has carried out technical transformation on the off-site pharmaceutical production line of Dongguan Xie Shi (Xingning) Industrial Transfer Industrial Park. The investment of this project is1280,000 yuan, including fixed assets113.52 million yuan (77.68 million yuan for equipment and technology, 35.84 million yuan for civil engineering, public works and other investments) and the working capital is 65.84 million yuan. After the completion of the project, the annual production of Chinese and western medicines is 65.438+0.25 billion tablets, 3.2 million capsules, 6.8 million powders, 4.5 million honey pills and 6.5438+0.2 million water pills. The sales income is 250 million yuan, the profit is 72 million yuan, and the development space with an annual output value of more than 500 million yuan is reserved. The company is committed to caring for health, benefiting the people, and to the health cause of evergreen human life. We sincerely hope to cooperate with colleagues in the pharmaceutical industry and make greater contributions to the development of the pharmaceutical industry!
Legal Representative: Liu.
Established: 1997-05-23
Registered capital: 565,438,000 yuan.
Industrial and commercial registration number: 44148100010249.
Type of enterprise: other limited liability companies
Company Address: Industrial Transfer Industrial Park, Tang Ye Section of Xinghe Line, xingning city, Guangdong.